Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions
about
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.Human papillomavirus vaccination: a case study in translational scienceWAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motilityPapillomavirus E6 oncoproteins.Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.Depletion of the cdk inhibitor p16INK4a differentially affects proliferation of established cervical carcinoma cells.Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in miceNovel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprintingNonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique.Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma.Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model.Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivoMolecular events in uterine cervical cancer.Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study.Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation.Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patientsInhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7.Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions.Human papillomavirus genotyping and integration in ovarian cancer Saudi patients.Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.Does human papillomavirus cause pterygium?
P2860
Q24521626-CC53ACD7-E38D-4689-A363-6AA528EA0B22Q26853556-EBECFEC4-FBD1-4171-A94A-7EB0C0A07E65Q28507062-576C0703-34C8-468D-9747-ADFD347B5C72Q30410553-24AD34D7-2C45-4C01-BB88-27D74FE964AFQ33570484-4E85BB34-21A8-49B2-A353-FAFE253E17F0Q33602929-42B0B8A6-399E-4B93-89A6-31EF275C3A5DQ33696617-0FF4D0E9-2F4E-48AF-A2FC-4FDDC783149EQ33782147-2DD3FF72-EEDE-4201-A6C1-CDCD0039F7F6Q33842444-E93A4D9B-D3DD-4A80-97EE-EACF0A1C3738Q33951730-88004A42-45A8-4916-953C-BBB63C24FBB7Q34064235-C73294E3-1DCA-481D-AD32-FAA7596FE65EQ34074596-1C6F1263-507E-4B58-8510-E6176447F837Q34150408-7E9CCF18-99DE-4C12-B51A-EBE347C72382Q34415859-1F1E53AD-EDF6-480E-BBF4-E9F8144FD544Q34987709-7411745A-F572-4C96-BB30-627CEF7FC3DCQ35562096-1DAB4DF1-BBC3-4C09-AB89-EC651743A191Q35689066-7C58BF74-E451-4ECA-BFB5-20947C154C9EQ35848569-49073499-D591-4D29-B128-AA51D306F63CQ36183493-D2568E2B-6B79-49AE-9AA6-0712751C2A92Q36622790-34E812E0-0F70-46DA-B9C0-0AA4C24F3EF9Q36641723-A912147A-DBEE-469C-AA27-C02308D9B59FQ37009828-81E24E00-2188-4F2C-A830-CC59E925A97BQ37348056-0981010E-2682-42FB-AF42-B2B730F8CB99Q37588351-659BE462-317E-411B-96AE-3D01B5A2A8A1Q40962499-89CDA60F-4D3E-48E5-9FF4-03D9E2C2A50BQ43008521-EBE3A8AB-49C4-45E1-977D-EC4E9563300A
P2860
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@ast
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@en
type
label
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@ast
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@en
prefLabel
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@ast
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@en
P2093
P2860
P1433
P1476
Reversible repression of papil ...... E6-p53 and E7-pRB interactions
@en
P2093
Aengeneyndt F
Jansen-Dürr P
Rittmüller C
Spitkovsky D
von Knebel Doeberitz M
P2860
P304
P407
P577
1994-05-01T00:00:00Z